Last $28.57 USD
Change Today -0.80 / -2.72%
Volume 281.3K
HSTM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

healthstream inc (HSTM) Snapshot

Open
$29.30
Previous Close
$29.37
Day High
$29.43
Day Low
$28.42
52 Week High
01/13/14 - $34.64
52 Week Low
04/28/14 - $20.76
Market Cap
789.5M
Average Volume 10 Days
121.0K
EPS TTM
$0.37
Shares Outstanding
27.6M
EX-Date
--
P/E TM
77.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTHSTREAM INC (HSTM)

Related News

No related news articles were found.

healthstream inc (HSTM) Related Businessweek News

No Related Businessweek News Found

healthstream inc (HSTM) Details

HealthStream, Inc. provides suite of software-as-a-service solutions for the healthcare industry in the United States. The company operates in two segments, HealthStream Workforce Development Solutions and HealthStream Research/Patient Experience Solutions. The HealthStream Workforce Development Solutions segment provides training, assessment, and talent development and management solutions; and administrative and management tools, as well as implementation and account management services. This segment’s solutions comprise HealthStream Learning Center that provides educational activities and training courseware; Authoring Center, which enables healthcare organizations to create Internet-based courses; HealthStream Competency Center, an application for competency management; HealthStream Performance Center, an application for performance management; SimCenter, a suite of applications to accelerate the adoption of simulation-based learning; and HealthStream Connect, a content delivery platform for allowing access to content libraries. These solutions support healthcare administrators in configuring training for various groups of employees, modifying training materials, and documenting training completion, as well as facilitating competency assessments and performance appraisals. The HealthStream Research/Patient Experience Solutions segment provides various surveys, such as Patient Insights, Employee Insights, Physician Insights, and Community Insights; data analyses of survey results; and other research-based measurement tools. This segment’s services provide analyses with recommendations; benchmarking capability; and consulting services. The company markets its products and services to healthcare organizations, pharmaceutical and medical device companies, and other participants in the healthcare industry through its direct sales teams, consultants, and account relationship managers. HealthStream, Inc. was founded in 1990 and is headquartered in Nashville, Tennessee.

598 Employees
Last Reported Date: 03/4/14
Founded in 1990

healthstream inc (HSTM) Top Compensated Officers

Co-Founder, Chairman of the Board, Chief Exec...
Total Annual Compensation: $265.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $237.7K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $252.1K
Executive Vice President
Total Annual Compensation: $241.8K
Senior Vice President of Business Development
Total Annual Compensation: $198.9K
Compensation as of Fiscal Year 2013.

healthstream inc (HSTM) Key Developments

Healthstream Inc. Presents at Stifel Healthcare Conference 2014, Nov-19-2014 01:50 PM

Healthstream Inc. Presents at Stifel Healthcare Conference 2014, Nov-19-2014 01:50 PM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Robert A. Frist, Co-Founder, Chairman of the Board, Chief Executive Officer and President.

Healthstream Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Fiscal Year 2014

Healthstream Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net income of $3.436 million or $0.12 per basic and diluted share on revenues of $44.525 million compared to net income of $2.296 million or $0.08 per basic and diluted share on revenues of $33.659 million a year ago. Income before income taxes was $4.790 million compared to $3.925 million a year ago. Operating income was $4.741 million compared to $3.879 million a year ago. Adjusted EBITDA was $7.933 million compared to $6.286 million a year ago. Non-GAAP operating income was $4.891 million compared to $4.046 million a year ago. Non-GAAP net income was $3.544 million compared to $2.394 million a year ago. Non-GAAP revenue was $44.675 million compared to $33.826 million a year ago. For the nine months, the company reported net income of $7.747 million or $0.28 per basic and diluted share on revenues of $125.351 million compared to net income of $6.658 million or $0.24 per diluted share on revenues of $95.224 million a year ago. Income before income taxes was $12.226 million compared to $11.278 million a year ago. Operating income was $12.149 million compared to $11.157 million a year ago. Net cash provided by operating activities was $28.675 million compared to $23.211 million a year ago. Purchases of property and equipment were $3.044 million compared to $2.414 million a year ago. Payments associated with capitalized software development were $4.025 million compared to $3.017 million a year ago. Adjusted EBITDA was $21.274 million compared to $18.027 million a year ago. Non-GAAP operating income was $13.371 million compared to $11.824 million a year ago. Non-GAAP net income was $8.519 million compared to $7.052 million a year ago. Non-GAAP revenue was $126.573 million compared to $95.891 million a year ago. For the fiscal year 2014, the company anticipates consolidated revenues will grow by 28 to 30% as compared to 2013, which revenue growth includes the impact of the deferred revenue write-down related to the HCCS acquisition. Full-year operating income will increase between 5% to 10% as compared to full-year 2013 results. This operating income estimated range includes approximately $2.0 million related to the combined impact of the deferred revenue write-down primarily related to the HCCS acquisition, amortization of acquired intangibles, incremental investments in HCCS related sales, marketing, product development to drive future growth, and approximately $365,000 of transaction costs associated with the HCCS acquisition. The company expects 2014 capital expenditures will be between $9.0 million and $10.0 million. The company expects effective tax rate to be between 37% and 39%. This effective tax rate incorporates the research and development tax credits the Company recognized in the third quarter of 2014.

Healthstream Inc. to Report Q3, 2014 Results on Oct 20, 2014

Healthstream Inc. announced that they will report Q3, 2014 results on Oct 20, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSTM:US $28.57 USD -0.80

HSTM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Computer Programs & Systems Inc $60.77 USD -0.16
Enzo Biochem Inc $4.68 USD 0.00
Luminex Corp $18.46 USD +0.09
Merge Healthcare Inc $3.59 USD +0.05
Saba Software Inc $8.70 USD +0.10
View Industry Companies
 

Industry Analysis

HSTM

Industry Average

Valuation HSTM Industry Range
Price/Earnings 84.0x
Price/Sales 4.9x
Price/Book 4.9x
Price/Cash Flow 40.5x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHSTREAM INC, please visit www.healthstream.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.